What is the Vijaya Diagnostic Centre Ltd share price today?

The share price of NSE:VIJAYA-EQ on 01 Oct 2026 (as of 15:05:12 IST) is ₹1430.9.

What is the NSE:VIJAYA-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:VIJAYA-EQ 52 week high low range shows a high of ₹1593.6 and a low of ₹848.

What is the Vijaya Diagnostic Centre Ltd market cap?

As on 01 Oct 2026, Vijaya Diagnostic Centre Ltd market cap is ₹147951000000.

What is the shareholding pattern of Vijaya Diagnostic Centre Ltd Stock?

The shareholding pattern of Vijaya Diagnostic Centre Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 52.51% Foreign Institutional Investors (FII): 11.65% Domestic Institutional Investors (DII): 0.95% Mutual Funds: 30.66% Retail & Others: 4.23% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Vijaya Diagnostic Centre Ltd?

The Price-to-Earnings (PE) ratio of Vijaya Diagnostic Centre Ltd is 78.9123, and the Price-to-Book (PB) ratio is 9.2898, as on 01 Oct 2026.

Vijaya Diagnostic Centre Share Price

1447.10-10.30 (-0.71%)

+41.91% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.71%

1 Week

+0.10%

1 Month

+1.75%

3 Month

+5.64%

6 Month

+13.15%

YTD

+36.39%

1 Year

+41.91%

5 Year

+156.17%

10 Year

Max

+167.98%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1431.00

1429.10

1335.00

1212.00

848.00

High

1474.40

1475.70

1501.00

1593.60

About

Vijaya Diagnostic Centre is India’s largest B2C-focused integrated diagnostic chain, providing a comprehensive range of radiology and pathology tests with a focus on delivering high-quality services at affordable prices. It Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

VIJAYANSE

LTP

1W Low

1W High

Market cap (₹)

8440+240 (2.93%)

8176

8459

1,21,067Cr

895.5+44.35 (5.21%)

849.40

905.50

85,955Cr

645.2+6.4 (1.00%)

633.25

673.90

85,953Cr

681.35+2.15 (0.32%)

668.70

690.95

58,742Cr

785.55+30.65 (4.06%)

745

785.55

57,377Cr

1870.6+156.1 (9.10%)

1705.20

1924.30

37,545Cr

1325.8+26.1 (2.01%)

1260

1342.70

34,919Cr

1925.7+14 (0.73%)

1856.50

1958

31,682Cr

731.75+29.25 (4.16%)

694.05

737.60

30,276Cr

511+22.3 (4.56%)

487

529

16,301Cr

1447.1-17.1 (-1.17%)

1429.10

1478.90

15,015Cr

Vijaya Diagnostic Centre Share Price

1447.10-10.30 (-0.71%)

+41.91% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years17%

3 years21%

Last year19%

Compounded Profit Growth

10 years-

5 years15%

3 years27%

Last year20%

Stock Price CAGR

10 years-

5 years21%

3 years36%

1 year42%

Return on Equity

10 years22%

5 years21%

3 years20%

Last year20%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	17%	21%	19%
-	15%	27%	20%
-	21%	36%	42%
22%	21%	20%	20%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

VIJAYA

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,440	₹121067 Cr	57.94	40.39	207.67	₹1942 Cr
895.5	₹85955 Cr	62.26	4.26	19.36	₹1442 Cr
645.2	₹85953 Cr	96.33	1.96	11.95	₹892 Cr
681.35	₹58742 Cr	184.33	0.31	6.76	₹388 Cr
785.55	₹57377 Cr	54.75	3.53	20.1	₹1042 Cr
1,870.6	₹37545 Cr	43.72	14.73	71.14	₹806 Cr
1,325.8	₹34919 Cr	62.78	5.91	29.85	₹556 Cr
1,925.7	₹31682 Cr	58.46	10.11	42.51	₹505 Cr
731.75	₹30276 Cr	148.2	1.04	12.74	₹241 Cr
511	₹16301 Cr	109.87	1.43	13.88	₹133 Cr
1,447.1	₹15015 Cr	80.08	5.16	27.53	₹173 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
₹231 Cr	₹219 Cr	₹205 Cr	₹202 Cr	₹188 Cr	₹173 Cr	₹169 Cr	₹183 Cr	₹156 Cr	₹155 Cr	₹133 Cr	₹139 Cr	₹121 Cr	₹121 Cr	₹113 Cr	₹121 Cr	₹104 Cr	₹116 Cr	₹111 Cr	₹113 Cr	₹123 Cr	₹112 Cr	₹100 Cr	₹113 Cr
₹9 Cr	₹2 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹5 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹2 Cr
₹240 Cr	₹222 Cr	₹210 Cr	₹208 Cr	₹195 Cr	₹179 Cr	₹174 Cr	₹187 Cr	₹160 Cr	₹158 Cr	₹138 Cr	₹146 Cr	₹127 Cr	₹126 Cr	₹117 Cr	₹124 Cr	₹107 Cr	₹119 Cr	₹114 Cr	₹116 Cr	₹126 Cr	₹116 Cr	₹103 Cr	₹116 Cr
₹158 Cr	₹148 Cr	₹143 Cr	₹142 Cr	₹135 Cr	₹123 Cr	₹120 Cr	₹124 Cr	₹112 Cr	₹108 Cr	₹95 Cr	₹95 Cr	₹85 Cr	₹83 Cr	₹89 Cr	₹88 Cr	₹79 Cr	₹84 Cr	₹76 Cr	₹74 Cr	₹78 Cr	₹70 Cr	₹66 Cr	₹76 Cr
₹107 Cr	₹98 Cr	₹91 Cr	₹88 Cr	₹81 Cr	₹74 Cr	₹72 Cr	₹80 Cr	₹65 Cr	₹66 Cr	₹57 Cr	₹64 Cr	₹54 Cr	₹54 Cr	₹48 Cr	₹52 Cr	₹43 Cr	₹51 Cr	₹51 Cr	₹54 Cr	₹60 Cr	₹59 Cr	₹49 Cr	₹54 Cr
₹11 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr
₹71 Cr	₹64 Cr	₹58 Cr	₹58 Cr	₹52 Cr	₹47 Cr	₹47 Cr	₹57 Cr	₹42 Cr	₹44 Cr	₹35 Cr	₹45 Cr	₹35 Cr	₹37 Cr	₹22 Cr	₹31 Cr	₹24 Cr	₹31 Cr	₹34 Cr	₹38 Cr	₹44 Cr	₹43 Cr	₹33 Cr	₹36 Cr
₹53 Cr	₹48 Cr	₹43 Cr	₹43 Cr	₹39 Cr	₹35 Cr	₹35 Cr	₹42 Cr	₹32 Cr	₹34 Cr	₹26 Cr	₹34 Cr	₹26 Cr	₹28 Cr	₹16 Cr	₹23 Cr	₹18 Cr	₹24 Cr	₹25 Cr	₹28 Cr	₹33 Cr	₹32 Cr	₹25 Cr	₹27 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
—	—	—	—	—	—	—	—
₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹5 Cr	₹5 Cr	₹7 Cr
₹3 Cr	₹16 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹83 L	₹0	₹0
₹944 Cr	₹773 Cr	₹646 Cr	₹533 Cr	₹456 Cr	₹354 Cr	₹270 Cr	₹200 Cr
₹944 Cr	₹773 Cr	₹646 Cr	₹533 Cr	₹456 Cr	₹354 Cr	₹270 Cr	₹200 Cr
₹957 Cr	₹799 Cr	₹657 Cr	₹545 Cr	₹468 Cr	₹359 Cr	₹275 Cr	₹207 Cr
₹0	₹0	₹3 Cr	₹2 Cr	₹1 Cr	₹23 L	-₹40 L	-₹37 L
₹0	₹0	₹0	₹0	₹0	₹0	₹28 Cr	₹37 Cr
₹0	₹0	₹0	₹0	₹0	₹3 Cr	-₹6 Cr	-₹6 Cr
₹15 Cr	₹5 Cr	-₹3 Cr	-₹8 Cr	-₹9 Cr	-₹6 Cr	-₹2 Cr	-₹1 Cr
₹400 Cr	₹297 Cr	₹239 Cr	₹233 Cr	₹170 Cr	₹127 Cr	₹121 Cr	₹105 Cr
₹11 Cr	₹10 Cr	₹11 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹5 Cr
₹426 Cr	₹312 Cr	₹247 Cr	₹232 Cr	₹169 Cr	₹132 Cr	₹148 Cr	₹141 Cr
—	—	—	—	—	—	—	—
₹38 Cr	₹33 Cr	₹33 Cr	₹28 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr
₹77 Cr	₹120 Cr	₹36 Cr	₹32 Cr	₹41 Cr	₹19 Cr	₹33 Cr	₹31 Cr
₹0	₹0	₹0	₹0	₹63 L	₹1 Cr	₹1 Cr	₹2 Cr
₹9 Cr	₹9 Cr	₹4 Cr	₹6 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr
₹124 Cr	₹163 Cr	₹73 Cr	₹66 Cr	₹66 Cr	₹44 Cr	₹59 Cr	₹57 Cr
₹1507 Cr	₹1274 Cr	₹980 Cr	₹845 Cr	₹705 Cr	₹535 Cr	₹481 Cr	₹405 Cr
₹13 L	₹13 L	₹0	₹0	₹0	₹0	₹6 L	₹6 L
₹0	₹0	₹0	₹0	₹63 L	₹4 Cr	₹33 Cr	₹42 Cr
—	—	—	—	—	—	—	—
₹1544 Cr	₹1261 Cr	₹1069 Cr	₹800 Cr	₹589 Cr	₹437 Cr	₹392 Cr	₹349 Cr
₹475 Cr	₹396 Cr	₹327 Cr	₹276 Cr	₹219 Cr	₹169 Cr	₹121 Cr	₹89 Cr
₹1069 Cr	₹865 Cr	₹742 Cr	₹524 Cr	₹370 Cr	₹268 Cr	₹272 Cr	₹259 Cr
₹34 Cr	₹70 Cr	₹8 Cr	₹27 Cr	₹34 Cr	₹8 Cr	₹9 Cr	₹3 Cr
₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L
₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L	₹4 L
₹44 Cr	₹9 Cr	₹15 Cr	₹15 Cr	₹27 Cr	₹10 Cr	₹11 Cr	₹6 Cr
₹37 Cr	₹22 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹9 Cr	₹2 Cr	₹14 L
₹1185 Cr	₹966 Cr	₹769 Cr	₹569 Cr	₹435 Cr	₹296 Cr	₹294 Cr	₹268 Cr
—	—	—	—	—	—	—	—
₹228 Cr	₹185 Cr	₹109 Cr	₹139 Cr	₹54 Cr	₹28 Cr	₹55 Cr	₹69 Cr
₹5 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr
₹21 Cr	₹15 Cr	₹16 Cr	₹9 Cr	₹10 Cr	₹7 Cr	₹8 Cr	₹9 Cr
₹53 Cr	₹49 Cr	₹73 Cr	₹116 Cr	₹192 Cr	₹194 Cr	₹118 Cr	₹53 Cr
₹6 Cr	₹4 Cr	₹3 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹2 Cr	₹4 Cr
₹9 Cr	₹50 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹87 L	₹1 Cr	₹64 L
₹322 Cr	₹307 Cr	₹211 Cr	₹276 Cr	₹270 Cr	₹239 Cr	₹186 Cr	₹137 Cr
₹198 Cr	₹145 Cr	₹138 Cr	₹209 Cr	₹204 Cr	₹195 Cr	₹128 Cr	₹80 Cr
₹1507 Cr	₹1274 Cr	₹980 Cr	₹845 Cr	₹705 Cr	₹535 Cr	₹481 Cr	₹405 Cr
₹93	₹76	₹64	₹53	₹46	₹79	₹606	₹453
₹93	₹76	₹64	₹53	₹46	₹35	₹27	₹20

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
₹233 Cr	₹193 Cr	₹159 Cr	₹114 Cr	₹147 Cr	₹112 Cr	₹83 Cr	₹65 Cr
₹107 Cr	₹79 Cr	₹60 Cr	₹68 Cr	₹57 Cr	₹53 Cr	₹49 Cr	₹43 Cr
-₹17 Cr	-₹7 Cr	-₹1 Cr	₹9 Cr	-₹7 Cr	-₹5 Cr	-₹3 Cr	₹80 L
₹323 Cr	₹264 Cr	₹217 Cr	₹191 Cr	₹198 Cr	₹161 Cr	₹129 Cr	₹109 Cr
₹271 Cr	₹224 Cr	₹183 Cr	₹165 Cr	₹158 Cr	₹130 Cr	₹106 Cr	₹91 Cr
-₹174 Cr	-₹182 Cr	-₹142 Cr	-₹110 Cr	-₹123 Cr	-₹130 Cr	-₹31 Cr	-₹90 Cr
-₹69 Cr	-₹52 Cr	-₹45 Cr	-₹42 Cr	-₹31 Cr	-₹49 Cr	-₹30 Cr	-₹7 Cr
₹27 Cr	-₹9 Cr	-₹4 Cr	₹13 Cr	₹4 Cr	-₹49 Cr	₹46 Cr	-₹6 Cr
₹13 Cr	₹22 Cr	₹24 Cr	₹11 Cr	₹7 Cr	₹56 Cr	₹10 Cr	₹16 Cr
₹0	₹0	₹2 Cr	₹0	₹0	₹0	₹0	₹0
₹40 Cr	₹13 Cr	₹22 Cr	₹24 Cr	₹11 Cr	₹7 Cr	₹56 Cr	₹10 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Vijaya Diagnostic Centre Share Price

1447.10-10.30 (-0.71%)

+41.91% past 1 Year

Shareholding summary

Promoters

52.46%

FII

10.67%

DII

1.05%

31.44%

Others

4.38%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
52.46%	52.51%	52.51%	52.60%	52.60%	52.63%
10.67%	11.65%	13.38%	15.10%	18.27%	19.56%
1.05%	0.95%	0.87%	0.62%	0.54%	0.52%
31.44%	30.66%	29.06%	27.98%	24.80%	23.55%
4.38%	4.23%	4.18%	3.70%	3.79%	3.74%

Bulk & block deals

Name

Graviton Research Capital Llp

Hrti Private Limited

Graviton Research Capital Llp

Nk Securities Research Private Limited

Hrti Private Limited

Graviton Research Capital Llp

Nk Securities Research Private Limited

Graviton Research Capital Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
08 Apr 2025	Purchase	115.10 Cr	₹983.51	11.70 L	Bulk	1.139299	NSE
08 Apr 2025	Sell	115.13 Cr	₹983.69	11.70 L	Bulk	1.139299	NSE
04 Mar 2025	Sell	78.54 Cr	₹1,020.52	7.70 L	Bulk	0.749166	NSE
04 Mar 2025	Purchase	121.47 Cr	₹1,029.06	11.80 L	Bulk	1.149088	NSE
04 Mar 2025	Purchase	53.65 Cr	₹1,023.88	5.24 L	Bulk	0.510068	NSE
04 Mar 2025	Purchase	83.03 Cr	₹1,019.30	8.15 L	Bulk	0.792986	NSE
04 Mar 2025	Sell	121.53 Cr	₹1,029.53	11.80 L	Bulk	1.149088	NSE
04 Mar 2025	Sell	53.67 Cr	₹1,024.35	5.24 L	Bulk	0.510068	NSE
27 Feb 2025	Purchase	58.37 Cr	₹975.72	5.98 L	Bulk	0.582374	NSE
27 Feb 2025	Sell	58.45 Cr	₹977.10	5.98 L	Bulk	0.582374	NSE

Insider trading & SAST

Client name

Hdfc Mutual Fund

Abrdn Asia Ltd

Wasatch Advisors Lp

Kotak Mahindra Mutual Fund

Wasatch Advisors Lp (Revised)

Wasatch Advisors Lp

Icici Prudential Mutual Fund

Wasatch Advisors Lp

Icici Prudential Mutual Fund

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
13 Aug 2026	Other	Acquisition	—	5	—	6.34 K	27 Jul 2026	Market	51,47,641	SAST	29(1)	—
13 Aug 2026	Other	Disposal	0.12	3.23	—	1.33 L	29 Jun 2026	Market	33,31,046	SAST	29(2)	—
10 Mar 2026	Other	Disposal	0.02	3.74	—	23.61 K	19 Feb 2026	Market	38,54,484	SAST	29(2)	—
13 Nov 2024	Other	Acquisition	0.06	5.06	—	67.27 K	07 Nov 2024	Market	51,98,217	SAST	29(1)	—
02 Sep 2024	Other	Disposal	2.93	5.76	—	30.03 L	08 Jul 2024	Off Market Transfer	59,08,535	SAST	29(1)	—
19 Jul 2024	Other	Disposal	4	5.76	—	4.07 L	08 Jul 2024	—	59,08,535	SAST	29(1)	—
30 Jan 2024	Other	Disposal	2.01	3.01	—	20.41 L	20 Jun 2023 - 25 Jan 2024	Market	30,78,473	SAST	29(2)	—
02 Nov 2023	Other	Acquisition	2.03	9.76	—	21.03 L	31 Oct 2023	Market	99,83,327	SAST	29(1)	—
02 Nov 2023	Other	Acquisition	2.03	9.76	—	21.03 L	31 Oct 2023	Market	99,83,327	SAST	29(2)	—
07 Jul 2023	Other	Acquisition	0.05	5.02	—	52.81 K	19 Jun 2023	Market	51,19,201	SAST	29(1)	—

Vijaya Diagnostic Centre Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Vijaya Diagnostic Centre Share Price

Vijaya Diagnostic Centre Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Vijaya Diagnostic Centre Share Price

Vijaya Diagnostic Centre Share Price

Oscillators

Moving averages

Vijaya Diagnostic Centre Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Vijaya Diagnostic Centre Share Price

Corporate Actions

Company details

Vijaya Diagnostic Centre Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Vijaya Diagnostic Centre Share Price

News

Vijaya Diagnostic Centre Reports Stronger Second Quarter EBITDA Growth

Vijaya Diagnostic Centre Reports Strong Year On Year Profit Growth

Vijaya Diagnostic Centre Reports Strong Second Quarter Revenue Growth

Vijaya Diagnostic Centre board approves Assam diagnostic operations acquisition

Vijaya Diagnostic Centre schedules analyst and investor meet on 10 September

Vijaya Diagnostic Centre Q1 EBITDA rises with improved operating margin performance

Vijaya Diagnostic Centre posts strong Q1 revenue growth on YoY basis

Vijaya Diagnostic Centre reports strong Q1 profit growth on yearly basis

Vijaya Diagnostic Centre sees Rs 57.09 crores NSE block trade at Rs 1,349.50

Vijaya Diagnostic Centre sees Rs 15.29 crore NSE block trade activity

Block deal in Vijaya Diagnostic Centre on NSE worth Rs 16.19 crores

Vijaya Diagnostic Centre informs about investors meet

Block trade reported in Vijaya Diagnostic Centre shares on NSE at premium pricing

Vijaya Diagnostic Plans Rs 140-150 Crore Capex for FY27 to Build Fully Automated Lab in Hyderabad

Vijaya Diagnostic Centre Q4 EBITDA Rises 38.5% YoY to Rs 95.50 Crores, Margin Expands to 43.54%

Vijaya Diagnostic Centre Q4 Consolidated Net Profit Rises 38% YoY to Rs 47.90 Crores

Vijaya Diagnostic reports Profit after tax of 52.65 Crores, in the March 2026 quarter

Vijaya Diagnostic Centre NSE Block Trade: Rs 22.47 Crores for 200,103 Shares

Vijaya Diagnostic Centre informs about certificate

Vijaya Diagnostic Centre informs about disclosure

Vijaya Diagnostic Centre Ltd Share Price Today

Vijaya Diagnostic Centre Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator